| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/06/2004 | WO2004022700A3 Antifreeze proteins isolated from forage grasses and methods for their use |
| 05/06/2004 | WO2004022587A3 A pair of polypeptides with specific and strong interaction |
| 05/06/2004 | WO2004016775A3 Plants having modified growth and a method for making the same |
| 05/06/2004 | WO2004015113A3 Albumin-fused ciliary neurotrophic factor |
| 05/06/2004 | WO2004014953A3 Anti-myelin associated glycoprotein (mag) antibodies |
| 05/06/2004 | WO2004013629A3 Screening for agents suitable for treatment of leukocyte associated inflammatory diseases |
| 05/06/2004 | WO2004011676A3 Multi-reporter gene model for toxicological screening |
| 05/06/2004 | WO2004011606A3 Macromolecular protection assay |
| 05/06/2004 | WO2004007536A3 Interactions of the epstein-barr virus protein ebna1, and uses thereof |
| 05/06/2004 | WO2004005506A3 Bacterial cell digestion by means of domain 3 of ef-tu |
| 05/06/2004 | WO2004005334A3 Nucleic acid molecule encoding an allergen preprotein of a mite of genus dermatophagoides or euroglyphus and use thereof for protecting said allergen in plants |
| 05/06/2004 | WO2004001068A3 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 05/06/2004 | WO2003106631A3 Methods and compositions relating to labeled rna molecules that reduce gene expression |
| 05/06/2004 | WO2003105891A3 Use of hec1 antagonists in the treatment of proliferative disorders and cancer |
| 05/06/2004 | WO2003104462A3 Regulation of gene expression using chromatin remodelling factors |
| 05/06/2004 | WO2003102141A3 Identification of a gene causing the most common form of bardet-biedl syndrome and uses thereof |
| 05/06/2004 | WO2003101376A3 Topical use of at least one double-stranded rna oligonucleotide (ds rna) |
| 05/06/2004 | WO2003100028A3 Tr2, tr4, tr2/tr4 double knockouts and uses thereof |
| 05/06/2004 | WO2003099997A3 Methods and compositions for regulation and manipulation of steroidogenesis |
| 05/06/2004 | WO2003099318A3 Pancreas-specific proteins |
| 05/06/2004 | WO2003093414A3 Transgenic animal model for spliceosome-mediated rna trans-splicing |
| 05/06/2004 | WO2003093291A3 Antisense oligonucleotides for identifying drug targets and enhancing cancer therapies |
| 05/06/2004 | WO2003090695A3 TREATMENT OF α-GALACTOSIDASE A DEFICIENCY |
| 05/06/2004 | WO2003086470A3 Smac-peptides as therapeutics against cancer and autoimmune diseases |
| 05/06/2004 | WO2003064469A8 Regulation of human hematopoietin receptor-like protein |
| 05/06/2004 | WO2003057843A8 Methods and materials for modulating trpc4 |
| 05/06/2004 | WO2003048377A3 Multiplex real-time quantitative pcr |
| 05/06/2004 | WO2003048186B1 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
| 05/06/2004 | WO2003045316A9 Polynucleotide therapy |
| 05/06/2004 | WO2003044168A9 Facilitation of rna interference |
| 05/06/2004 | WO2003031567A9 Precursor conversion screening methods |
| 05/06/2004 | WO2003025019A9 Anti-pdgf antibodies and methods for producing engineered antibodies |
| 05/06/2004 | WO2003024200A8 Production of transgenic birds using stage x primordial germ cells |
| 05/06/2004 | WO2003022298A3 Use of a protein of the crmp family for treating diseases related to the immune system |
| 05/06/2004 | WO2003020016A3 SEED SPECIFIC 7S α PROMOTER FOR EXPRESSING GENES IN PLANTS |
| 05/06/2004 | WO2003020015A3 Methods to produce transgenic plants resistant to osmotic stress |
| 05/06/2004 | WO2003011903A3 Identification of specific tumor antigens by means of the selection of cdna libraries with sera |
| 05/06/2004 | WO2003010314A3 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 05/06/2004 | WO2002098456A3 Antigens and vectors for vaccination |
| 05/06/2004 | WO2002091995A8 Method to induce neovascular formation and tissue regeneration |
| 05/06/2004 | WO2002087510A3 Subcellular targeting of therapeutic proteins |
| 05/06/2004 | WO2002079387A9 Modular molecular clasps and uses thereof |
| 05/06/2004 | WO2002074787A3 Compositions and methods for identifying, characterizing, optimizing and using ligands to transcytotic molecules |
| 05/06/2004 | WO2002074251A9 Monoclonal antibody therapy for pancreas cancer |
| 05/06/2004 | WO2002072017A9 Method of drug target validation |
| 05/06/2004 | WO2002068462A9 Internal standard for electrophoretic and chromatographic separation processes |
| 05/06/2004 | WO2002064737A3 Antisense modulation of protein phosphatase 2 catalytic subunit beta expression |
| 05/06/2004 | WO2002062949A9 Aptamer-mediated regulation of gene expression |
| 05/06/2004 | WO2002061113A9 Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation |
| 05/06/2004 | WO2002057418A9 Methods of producing polyketide synthase mutants and compositions and uses thereof |
| 05/06/2004 | WO2002038108A3 Methods of treating disorders related to apoe |
| 05/06/2004 | WO2002026959A9 Nuclear reprogramming using iwsi and related chromatin remodeling atpases |
| 05/06/2004 | WO2002014463A3 Method for genetic transformation of woody trees |
| 05/06/2004 | WO2002000838A3 Recombinant minimal catalytic vanadium haloperoxidases and their uses |
| 05/06/2004 | WO2000077167A3 Herpes simplex virus amplicon vector targeting system and method of using same |
| 05/06/2004 | US20040088766 Genes regulating circadian clock function and photoperiodism |
| 05/06/2004 | US20040088765 Animal immunocontraceptives expressed in plants and uses thereof |
| 05/06/2004 | US20040088764 Transforming plants or plant cells using transcriptional controls of host nuclear promoter and translational plasmid; heterolgous gene expression and bioreactors |
| 05/06/2004 | US20040088763 Comprises nucleotide sequences coding protein which induces flowering in plants; genetic engineering and rice yields |
| 05/06/2004 | US20040088762 Comprises DNA for identification of nucleotide sequences associated with miniaturization of plants; insect resistance |
| 05/06/2004 | US20040088761 Gene concerning brassinosteroid-sensitivity of plants and utilization thereof |
| 05/06/2004 | US20040088760 Comprises nucleotide sequences coding promoter elements associated with chlorophyllous and/or embryonic seed tissue specific expression of heterologous proteins in cotton; bioreactors |
| 05/06/2004 | US20040088757 Comprises monopartite RNA viral vector for transformation and expression of heterologous genes in plants |
| 05/06/2004 | US20040088756 Identifying diseases resistance gene in plants |
| 05/06/2004 | US20040088755 Inhibitors of plant peptide deformylase for use as broad -spectrum herbicides and methods for identifying the same |
| 05/06/2004 | US20040088754 Comprises nucleotide sequences comprising heterologous polypeptide gene, signal sequences and seed maturation promoter for transformation and expression of polypeptide in preferential tissue/compartments of plants; bioreactors |
| 05/06/2004 | US20040088753 Gene encoding acetolactatic acid synthase gene |
| 05/06/2004 | US20040088752 Development of crop protection strategies that maximize the plant's "built-in" defense capabilities, or phytochemical defense mechanisms |
| 05/06/2004 | US20040088751 Comprises gene fragments coding polyhydroxyalkanoate synthase, acetoacetyl coa reductase and beta ketothiolase for transformation and generation of poly-3-hydroxyvalerate and poly-3-hydroxyoctanoate in plants; biodegradable polymers |
| 05/06/2004 | US20040088750 Production of enzymes in seeds and their use |
| 05/06/2004 | US20040088749 Comprises restoration of fertility (RF) polypeptide comprising pentatricopeptide repeat (PPR) for restoring fertility to male sterile plants; genetic engineering and selective plant breeding |
| 05/06/2004 | US20040088748 Method of performing transgenesis |
| 05/06/2004 | US20040088746 Apoptosis-inducing dna sequences |
| 05/06/2004 | US20040088745 Using expression vector coding heterologous gene associated with sex determination to generate animal models of preferential sex; veterinary medicine; animal husbandry; in vitro fertilization |
| 05/06/2004 | US20040088744 Fatty liver disease resistant bovines |
| 05/06/2004 | US20040088743 Non-human transgenic animal expressing ca-ahr |
| 05/06/2004 | US20040087784 Neuronal serine-threonine protein kinase |
| 05/06/2004 | US20040087778 Modified peptides as therapeutic agents |
| 05/06/2004 | US20040087777 Humanized antibodies that recognize beta amyloid peptide |
| 05/06/2004 | US20040087776 Methods for producing factor VIII proteins |
| 05/06/2004 | US20040087775 Process for production diphtheria toxin |
| 05/06/2004 | US20040087774 Comprises tumor necrosis factor receptor associated factor-(TRAF) inhibitor for diagnosis, prevention and tratment of tumors associated wit h epstein-barr virus |
| 05/06/2004 | US20040087771 Antimicrobial peptides of the family of defensins, polynucleotides encoding said peptides, transformed vectors and organisms containing them |
| 05/06/2004 | US20040087770 Viral peptide for use in diagnosing, preventing and treating sepsis and meningitis; microbiocides; vaccine development |
| 05/06/2004 | US20040087766 Interleukins; fusion proteins; solid phase synthesis; kits |
| 05/06/2004 | US20040087538 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 05/06/2004 | US20040087537 Compositions comprising fusion polypeptides HIV-Nef and NGF, and methods of using the same |
| 05/06/2004 | US20040087536 8-80 nucleobases that specifically hybridize to a nucleic acid molecule encoding a zinc finger protein (kox 1) to inhibit its expression |
| 05/06/2004 | US20040087535 Administering a nitric oxide synthase gene in the form of naked dna; angiogenesis inhibitors |
| 05/06/2004 | US20040087533 Antisense compounds, methods and compositions for treating MMP-12 related inflammatory disorders |
| 05/06/2004 | US20040087531 Inhibiting expression of gene tpt1 |
| 05/06/2004 | US20040087528 Delivering plasmid vector encoding HERG (A561V) (human ether-a-go-go related gene) protein to cells afflicted with re-entrant atrial flutter mediated cardiac arrhythmia |
| 05/06/2004 | US20040087526 Therapeutically useful compositions of DNA-RNA hybrid duplex constructs |
| 05/06/2004 | US20040087525 Polypeptide-human rna binding protein 19 and the polynucleotide encoding it |
| 05/06/2004 | US20040087524 Agent for postoperative use after removal of bone tumours |
| 05/06/2004 | US20040087523 Preventing or delaying infection, inflammation or tumor formation |
| 05/06/2004 | US20040087506 Methods of modulating FabH activity |
| 05/06/2004 | US20040087503 Modified ciliary neurotrophic factor (cntf ) with reduced immunogenicity |
| 05/06/2004 | US20040087481 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 05/06/2004 | US20040087478 Discovering pain regulating substances; incubating with then measuring binding to cell synthesized peptide or protein |